Key result
Hypertension was associated with a significantly higher prevalence of metabolic syndrome compared to normotension in high-altitude Tibetans (54.9% vs 15.6%, p<0.001).
Why the study?
The study was conducted to estimate the prevalence of metabolic syndrome and its components, associated factors, and component combinations according to hypertension status in Tibetans living at high altitude.
Cross-Sectional (n=1,473)
Yes
Absolute Event Rate: 54.9% vs 15.6%
p-value: p=<0.001
Metabolic syndrome and its components, particularly central obesity, are highly prevalent and cluster significantly more in hypertensive Tibetans living at high altitude compared to normotensive individuals.
Association supports metabolic screening in hypertensive high-altitude Tibetans; leaves open causal links and targeted interventions.
To estimate the prevalence of metabolic syndrome (MS) and metabolic components and their associated factors and component combinations according to hypertension status in Tibetans living at high altitude. Multistage sampling of 1473 participants (799 hypertensive patients and 674 normotensive subjects). MS prevalence and the number of metabolic components ≥ 3 were significantly higher in the hypertensive than normotensives. In hypertensive patients, the most common component was central obesity and it combined with: high blood pressure, in those with 2 risk factors, plus fasting hyperglycemia, in those with 3 risk factors, and high triglyceride, in those with 4 risk factors. In normotensive subjects, the most common single component was low high-density-lipoprotein cholesterol, and most component combination included central obesity and hyperglycemia in those with 2 risk factors, plus high blood pressure in those with 3 risk factors, and high triglycerides in those with 4 risk factors. Body mass index and female both were associated with increased possibilities of MS in hypertensive and normotensive participants. Low incoming, and high educational levels were associated with an elevated probability of MS in normotensive Tibetans also. The priority of prevention from cardiovascular diseases by targeting metabolic components in the hypertensive was different from normotensives. Different MS components had various lifestyle and socioeconomic factors.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2022) conducted a cross-sectional in Hypertension and Metabolic Syndrome (n=1,473). Hypertension vs. Normotension was evaluated on Prevalence of metabolic syndrome (MS) by IDF criteria (p=<0.001). Hypertension was associated with a significantly higher prevalence of metabolic syndrome compared to normotension in high-altitude Tibetans (54.9% vs 15.6%, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: